PurpleLab

PurpleLab announces Series B funding round led by Primus Capital Funds (Primus Capital), joining existing investor Edison Partners. The investment highlights PurpleLab’s growing role in simplifying the access to and interpretation of Real-World Data across the healthcare continuum. https://bit.ly/3RJrYio #RWD

🌉 San Francisco, here we come. On February 25-27, our team will be at LiveRamp’s RampUp 2025. 🚀 RampUp brings together marketing and tech innovators from around the globe to explore how data can transform brand affinity, fuel innovation, and create business value through collaboration. You know we’re passionate about leveraging real-world data to unlock insights that matter; from optimizing healthcare campaigns to driving targeted strategies, and connecting the dots between data and decision-making. Will we see you there? Let’s connect, share ideas, and exchange insights to continue pushing the boundaries of what’s possible with data in the healthcare space. Check out this link to schedule a meeting with us! https://lnkd.in/d6fr2fmW   #RampUp2025 #PurpleLab #HealthcareData

Gone are the days of sales reps knocking on doors; now it’s all about data, technology, and strategic thinking in pharma marketing. 🤓 We collaborated on an article with our partners at Datavant, VideoAmp, and CMI Media Group, where we dove into the seismic shifts happening in the industry, from the rise of healthcare data analytics (hello, real-world data!) to the empowered consumers who are doing their own research before even stepping into the doctor’s office. What does this new era of pharma marketing require? Precision, agility, and a little tech know-how that will help you achieve success. From navigating complex regulatory landscapes to shifting from mass marketing to more targeted, patient-centric campaigns, the industry is evolving faster than ever 💨. Thank you to Scott Ronay, Joe Kotz, Theodore Sweetser, and Jose Ferreira for the insightful discussion. 🙏 Read the article here: 🔗 https://lnkd.in/dmZ--V7S.  #PharmaMarketing #HealthcareData #DigitalTransformation #PatientCentric #TechInPharma #MarketingInnovation #PurpleLab

The devastating wildfires in Los Angeles have left entire neighborhoods in ashes, displaced thousands of families, and impacted vulnerable communities. In times like these, every small act of kindness makes a big difference.  If you’re looking for ways to help, here are some organizations making an impact on the ground. American Red Cross: Providing food, resources, and shelter to those fleeing the fires. Pasadena Humane: Caring for over 300 animals affected by the fires, providing medical treatment and safe housing. World Central Kitchen: Delivering meals and water to displaced residents. Direct Relief: Supplying emergency medical resources to first responders and those in need. Malibu Foundation: Offering food, shelter, and mental health support. Baby2Baby: Distributing diapers, formula, and essential supplies for children and families. Los Angeles Regional Food Bank: Ensuring food reaches those impacted. Canine Rescue Club: Supporting displaced dogs with medical care, housing, and transportation. Thanks Axios for highlighting the above organizations 👉 https://lnkd.in/gNfGCvFk 🚨 Know of other groups accepting donations or working on the ground to support wildfire victims? Please share them in the comments below to help increase visibility and drive support.

PurpleLab will join in on the action at SCOPE Summit 2025 in Orlando, FL 🌴 Book a meeting today 👉 https://lnkd.in/dHcDBHEv Our team is taking part in the 16th edition of the event that brings together the brightest minds across clinical trials, digital health, clinical research, patient care, and more! Swing by booth 417 to say hello and don’t miss Jared Safran, PharmD, MS from #PurpleLab and Karina D. from Parexel as they take the stage on February 6! See you in Orlando! 🙌 #SCOPEsummit #SCOPE2025 #ClinicalTrials #DigitalHealth #PatientCare #HealthcareInnovation #ClinicalResearch

We’re at it again! #PurpleLab’s health analytics data reveals a nearly 10% increase in #GLP1 prescriptions across the U.S. from 2023 to 2024. This surge highlights the growing demand for these medications, praised as game-changers in managing #obesity and #diabetes. Here’s a snapshot of what Tina Reed at Axios reported earlier in the week:  📈 Top Growth States: Rhode Island, Massachusetts, and New Jersey 📉 Declining States: Arkansas, Louisiana, West Virginia, Idaho, South Dakota, and Vermont 🩺 29% of prescriptions are aimed at adults aged 55–65; 26% are Seniors 65+ 🏥 Most prescriptions went to commercially insured patients, with #Medicaid patients accounting for just 9% of the total prescriptions in 2024. Our insights stem from analyzing 7.5 billion claims spanning private insurers, #Medicare, and Medicaid. Visit the article to learn more: https://lnkd.in/daSeggwj.

What if one platform could transform your prescription analytics and supercharge your advertising campaigns? Say hello to Prescription Measurement Report, your ultimate tool for data-driven insights. 📊 Prescription Measurement Report allows advertisers and agencies to: ✅ Dive into comprehensive prescriber metrics ✅ Track prescription activity volume and market share over time ✅ Uncover insights to optimize HCP prescribing behavior  ✅ Identify key opportunities and challenges to inform campaign strategies This is powered by our no-code platform HealthNexus: an interactive, customizable, and user-friendly solution for your analytics needs. #HealthcareAnalytics #PharmaMarketing #DataDriven #PurpleLab #PrescriptionAnalytics #AdTech

As we bid adieu to this year, we wanted to say a huge thank you 🤯 for all the brainstorming sessions, 🤝 collaborations, 👪 panel discussions, 📲 calls, and 📨emails that connected all of us during 2024! With 2025 right around the corner, we can’t wait to do it all over again! Here’s to an epic new year filled with success, growth, and way fewer “sorry, I was on mute” moments for all of us. 🥂 #HappyNewYear

The data-driven revolution in #pharma marketing is in full swing. As customer expectations evolve, so does our approach to sales, marketing, and #customerexperience. Data and analytics have become crucial for making informed decisions, personalizing engagements, and optimizing spend. Nowadays, leveraging data isn’t just a trend—it’s a strategic necessity for reducing costs and staying ahead of the game. 💪 In a recent roundtable hosted with DHC Group, we explored how the pharma industry is embracing #data innovation and shared insights on identity solutions, enhanced targeting, and the integration of physician and #consumerdata. Check out the full discussion here 🔗https://lnkd.in/dTdsaptK #PharmaMarketing #DataInnovation #DTCMarketing #MarketingAnalytics #HealthTech

🚨 Pharma product launches have a 40% miss rate. High-stakes investments in new drug launches demand more than traditional targeting methods. At PurpleLab’s recent Decoding Physician Prescribing Behaviour webinar, Theodore Sweetser shared: "If you’re thinking about plowing a billion dollars into go-to-market, 4 out of 10 times, it’s just not going to work out." Why? Because targeting just high-decile prescribers (a.k.a. the “usual suspects”) isn’t enough anymore. The data reveals that nurse practitioners (NPs) and physician assistants (PAs) often have the strongest connections with patients. The takeaway? Pharma marketers need a networked approach: ✅ Understand who’s really shaping prescribing decisions: from diagnosis to treatment. ✅ Use claims data to spot hidden influencers in a patient’s care journey. ✅ Blend digital tools with in-person connections for true omnichannel strategies. As PurpleLab’s Matthew Ryklin highlighted, LLMs and advanced analytics aren’t just buzzwords, they’re game-changers for crafting hyper-specific, data-driven campaigns. Success means broadening your circle, testing and learning quickly, and staying flexible in a rapidly changing healthcare landscape. Curious to learn more? Watch the full webinar for all the insights 👉 https://lnkd.in/dYQ5Yf5P #PharmaMarketing #DataDrivenDecisions #PurpleLab #HealthcareInnovation